PlainRecalls
FDA Drug Critical Class I Ongoing

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Reported: August 14, 2024 Initiated: July 18, 2024 #D-0626-2024

Product Description

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Reason for Recall

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Details

Recalling Firm
MAIN PRODUCTS INC
Units Affected
57, 340 bottles
Distribution
Nationwide within the U.S
Location
Chula Vista, CA

Frequently Asked Questions

What product was recalled?
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.. Recalled by MAIN PRODUCTS INC. Units affected: 57, 340 bottles.
Why was this product recalled?
Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2024. Severity: Critical. Recall number: D-0626-2024.